Amazon (AMZN) news · Oracle (ORCL) news
Oracle (ORCL) and AWZ (AMZN) expand long-term strategic collaboration agreement to accelerate customer migration, with Oracle AI Database AWS now available in 22 AWS Regions and offering new expanded capabilities
Newsquawk Staff ·
Oracle (ORCL) and AWZ (AMZN) expand long-term strategic collaboration agreement to accelerate customer migration, with Oracle AI Database AWS now available in 22 AWS Regions and offering new expanded capabilities.
What it means
This is the latest step in a pattern that has become familiar in enterprise software: a database incumbent extending its reach by running natively inside a rival cloud rather than defending a single-vendor stack. Multi-cloud availability agreements of this kind have historically been slow-burning revenue stories, where the immediate effect is muted but the strategic read-through is that the vendor concedes customers will not consolidate on its own cloud and opts to monetise them where they already sit. The mechanism to watch is migration economics: native availability inside AWS regions lowers the switching cost for Oracle's installed base, which supports licence and consumption revenue retention but also reduces the lock-in that has long underpinned the franchise. The regional count and expanded capabilities matter less for their current size than as a tell on how aggressively the two parties intend to push co-selling, since prior episodes of this type have only moved numbers materially once joint go-to-market and committed-spend arrangements followed. Worth noting that AWS is itself a competing database vendor, so the depth of the partnership is a signal about where each side sees the workload battle actually being fought. Follow-ons are disclosure of adoption metrics, any commentary on database revenue mix within Oracle's cloud line, and whether comparable arrangements with other hyperscalers deepen in parallel.
Sources
- OpenAI expects future AI models to be capable of identifying and exploiting vulnerabilities that are currently unknown, according to a blog post
- Texas Attorney General Ken Paxton sues OpenAI and CEO Sam Altman for lying to users and harming Texans
- OpenAI reveals plans for an in-house exabyte-scale storage system
- CrowdStrike (CRWD) CEO says in the coming months we will see a lot of breaches from the PHP vulnerability
- Oracle (ORCL) to invest USD 1bln in partner ecosystem over 4 years
Related headlines
- Daily US Earnings Estimates: 26th October 2026: VZ, WELL6 hours ago
- Newsquawk Weekly Economic Release 26th - 30th October 2026 10 hours ago
- Kimi K3.1 Pro AI model builds GTA VI-style (TTWO) playable game demo in just 10 hours for USD 52, developer claims on X; showcases AI’s ability to generate video game experiences - UNCONFIRMED5 hours ago
- US EQUITY OPEN: Breadth poor at the open: Energy leads gains on oil rally, Tech sees slight bounce10 hours ago
- US FDA approves subcutaneous induction regimen for AbbVie’s (ABBV) Skyrizi for adults with moderately to severely active Crohn’s disease4 hours ago
- The Trump administration plans to introduce voluntary “US Caught Seafood” labels to help consumers identify seafood origins, according to CBS8 hours ago
- Bristol Myers Squibb (BMY) spokesperson says the company has identified the cause of an earlier Car-T safety signal; will look to resume the paused trials in 20278 hours ago
- Republican Senator Blackburn has raised concerns about Meta’s (META) plans to update its commercial terms, warning that the changes could “exploit American creators and businesses,” according to a letter8 hours ago
- CNBC speculates that Verizon (VZ) would most likely be involved in the context of a partnership with SpaceX (SPCX)9 hours ago
- Ukraine President Zelensky says the Tesla (TSLA)/SpaceX (SPCX) Starlink and Starshield service remains slowed9 hours ago
- Meta (META) says it will extend the implementation date of updated commercial terms to November 20th (prev. October 30th); extension will allow it to explain the changes to partners and stakeholders11 hours ago
- Abbott (ABT) presents new ESMO data showing 30% absolute improvement in sensitivity with the whole-genome sequencing Oncodetect test in colorectal cancer11 hours ago
- Daily US Equity Opening News: SPCX explores access to 80K US cell sites; OpenAI nears USD 30bln funding at $1.25T valuation11 hours ago
- US BROKER MOVES: HESM upgraded at Raymond James; NCLH downgraded at JPM11 hours ago
- Bristol-Myers Squibb (BMY) says Iza-Bren reduced the risk of progression or death by 59% in Phase 3 breast cancer study; median PFS 8.2 months vs 4.0 months for chemotherapy; cORR 40.5% vs 20.2%; mDOR 6.9 vs 4.2 months12 hours ago